A mycophenolic acid prodrug. Immunosuppressive agent useful in prevention of organ allograft rejection. Is metabolized to mycophenolic acid in vivo which acts by inhibiting the biosynthesis of guanine nucleotides via inhibition of inosine 5’-monophosphate dehydrogenase, suppressing the...
Know who made it. See the evidence. Buy through one marketplace.
A mycophenolic acid prodrug. Immunosuppressive agent useful in prevention of organ allograft rejection. Is metabolized to mycophenolic acid in vivo which acts by inhibiting the biosynthesis of guanine nucleotides via inhibition of inosine 5’-monophosphate dehydrogenase, suppressing the production of proinflammatory cytokines, nitric oxide and LDH in macrophages. IL-2-dependent T cell proliferation is also inhibited. Inhibits microglial and astrocytic activation reducing cell death after neuronal injury. Active in vivo
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
